Beijing Northland Biotech. Co., Ltd.

beijing northland biotech. co., ltd. was established in june, 2004. our main business is the research & development of bio innovative pharmaceuticals and the industrialization of ophthalmic products. we are listed on neeq (national equities exchange and quotations) as 430047. our core technologies include: gene vector platform, biological macromolecule purification platform, prokaryotic cell culture platform, animal cell culture platform. to date, we have developed 7 new bio drugs as well as 11 patents. beijing northland biotech. co., ltd. has been qualified for the chinese national 11th and 12th five year development plans and continues to be supported by the chinese national government. as our development plan, we own 53,333㎡ in tongzhou area in beijing. huonland pharmaceutical co., ltd., a joint venture of beijing northland-bio(china) and huons(korea), the asia's biggest ophthalmic sterile eye drop plant, has been established as the first plan for the area. beijing northland biotech